LG 121071
Latest Information Update: 07 Feb 2001
Price :
$50 *
At a glance
- Originator Ligand Pharmaceuticals
- Class Pyridines; Quinolones; Small molecules
- Mechanism of Action Testosterone congener stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cachexia; Hypogonadism; Pregnancy
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Cachexia in USA (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Hypogonadism in USA (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Pregnancy (Prevention)/Male contraception in USA (Unknown route)